mTOR Signaling in Skeletal Myogenesis

骨骼肌生成中的 mTOR 信号转导

基本信息

  • 批准号:
    8037770
  • 负责人:
  • 金额:
    $ 31.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-06-01 至 2014-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Skeletal muscle differentiation is a well-orchestrated process regulated by autocrine, paracrine, and endocrine factors via a regulatory network of signal transduction pathways. In recent years the mammalian target of rapamycin (mTOR) has begun to be recognized as a critical regulator of skeletal muscle differentiation, growth and hypertrophy. Work from our laboratory has contributed to the current understanding of mTOR regulation of myoblast differentiation, and has led to the revelation that mTOR regulates multiple stages of myogenesis by assembling distinct pathways, some of which unexpected and yet to be fully delineated. With a combination of biochemical, molecular, cellular and genetic approaches, and utilizing both in vitro and in vivo systems, we aim to fill a sizable gap in the current knowledge of molecular pathways underlying the regulation of skeletal myogenesis by addressing these three major questions: (1) How are the known components of growth-regulating mTOR pathway involved in myogenesis, and what is the mTOR pathway(s) that regulates the initiation of myoblast differentiation in response to amino acids availability signals? (2) What is the mTOR pathway that specifically regulates the second-stage myocyte fusion critical for myotube/myofiber growth and maturation, and which secreted factors regulate this process? (3) What is mTOR's role in muscle regeneration and what are the mechanisms? Our expertise in biochemical characterization of signal transduction mechanisms, our strong preliminary data, and the unique animal models we have created, put us in an ideal position to tackle those questions. Knowledge gained in these studies will contribute to the molecular understanding of skeletal muscle development, repair, regeneration and hypertrophy. PUBLIC HEALTH RELEVANCE: Skeletal muscle differentiation is a well-orchestrated process regulated by autocrine, paracrine, and endocrine factors via multiple signal transduction pathways. Our proposed studies aim to dissect the molecular mechanisms underlying the regulation of skeletal muscle differentiation and regeneration, with a focus on the mammalian target of rapamycin signaling network. Knowledge gained in these studies will contribute to the molecular understanding of skeletal muscle biology, which may have significant impact on health-related issues such as muscular dystrophy, aging or disease-induced muscle atrophy, muscle regeneration, and exercise- induced muscle hypertrophy.
描述(由申请人提供):骨骼肌分化是通过信号转导途径的调节网络进行自分泌,旁分泌和内分泌因子调节的良好处理过程。近年来,雷帕霉素的哺乳动物靶标(MTOR)开始被认为是骨骼肌分化,生长和肥大的关键调节剂。我们实验室的工作有助于当前对MTOR调节成肌细胞分化的理解,并导致了MTOR通过组装不同的不同途径来调节肌发生的多个阶段的启示,其中一些途径是意外的,尚未完全划定。通过生化,分子,细胞和遗传方法的结合,并利用体外和体内系统,我们旨在填补当前对骨骼肌发生调节的分子途径的知识,通过解决这三个主要问题:(1)与之相关的成长过程:这可以调节响应氨基酸的可用性信号的肌细胞分化? (2)专门调节第二阶段心肌融合的MTOR途径是什么对Myotube/Myotiber生长和成熟至关重要的,哪些分泌的因素调节了这一过程? (3)MTOR在肌肉再生中的作用是什么?我们在信号转导机制的生化表征,强大的初步数据以及我们创建的独特动物模型方面的专业知识使我们处于解决这些问题的理想位置。这些研究中获得的知识将有助于对骨骼肌发育,修复,再生和肥大的分子理解。公共卫生相关性:骨骼肌分化是通过多种信号转导途径通过自分泌,旁分泌和内分泌因子调节的良好策划过程。我们提出的研究旨在剖析调节骨骼肌分化和再生的分子机制,重点是雷帕霉素信号网络的哺乳动物靶标。这些研究中获得的知识将有助于对骨骼肌生物学的分子理解,这可能会对与健康相关的问题产生重大影响,例如肌肉营养不良,衰老或疾病诱发的肌肉萎缩,肌肉再生,运动诱导的肌肉肥大。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jie Chen其他文献

Jie Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jie Chen', 18)}}的其他基金

The impact of hospital-based health information technology on health care quality and equity among patients with ADRD
基于医院的卫生信息技术对 ADRD 患者医疗保健质量和公平性的影响
  • 批准号:
    10729695
  • 财政年份:
    2023
  • 资助金额:
    $ 31.9万
  • 项目类别:
Effect of Hospital and Community Care Coordination on Health Care Quality and Equity among Individuals with Risk Factors or Diagnosis of ADRD
医院和社区护理协调对有 ADRD 危险因素或诊断的个体的医疗保健质量和公平性的影响
  • 批准号:
    10589023
  • 财政年份:
    2021
  • 资助金额:
    $ 31.9万
  • 项目类别:
Effect of Hospital and Community Care Coordination on Health Care Quality and Equity among Individuals with Risk Factors or Diagnosis of ADRD
医院和社区护理协调对有 ADRD 危险因素或诊断的个体的医疗保健质量和公平性的影响
  • 批准号:
    10353407
  • 财政年份:
    2021
  • 资助金额:
    $ 31.9万
  • 项目类别:
Effect of Hospital and Community Care Coordination on Health Care Access, Quality and Equity among Individuals with Risk Factors or Diagnosis of ADRD
医院和社区护理协调对有 ADRD 危险因素或诊断的个人的医疗保健获取、质量和公平性的影响
  • 批准号:
    9789164
  • 财政年份:
    2018
  • 资助金额:
    $ 31.9万
  • 项目类别:
Effects of Hospital-Community-Public Health Integration on Racial and Ethnic Disparities in Mental Health
医院-社区-公共卫生一体化对心理健康中种族和民族差异的影响
  • 批准号:
    9924656
  • 财政年份:
    2017
  • 资助金额:
    $ 31.9万
  • 项目类别:
Effects of Hospital-Community-Public Health Integration on Racial and Ethnic Disparities in Mental Health
医院-社区-公共卫生一体化对心理健康中种族和民族差异的影响
  • 批准号:
    10021780
  • 财政年份:
    2017
  • 资助金额:
    $ 31.9万
  • 项目类别:
Effects of Hospital-Community-Public Health Integration on Racial and Ethnic Disparities in Mental Health
医院-社区-公共卫生一体化对心理健康中种族和民族差异的影响
  • 批准号:
    9329801
  • 财政年份:
    2017
  • 资助金额:
    $ 31.9万
  • 项目类别:
Effect of Local Health Departments on Health Care Disparities for Individuals with Mental Health Disorders
当地卫生部门对精神健康障碍患者医疗保健差异的影响
  • 批准号:
    9199107
  • 财政年份:
    2016
  • 资助金额:
    $ 31.9万
  • 项目类别:
Effect of Local Health Departments on Health Care Disparities for Individuals with Mental Health Disorders
当地卫生部门对精神健康障碍患者医疗保健差异的影响
  • 批准号:
    9034884
  • 财政年份:
    2016
  • 资助金额:
    $ 31.9万
  • 项目类别:
Single-Molecule Dissection of mTOR Complexes
mTOR 复合物的单分子解剖
  • 批准号:
    8469719
  • 财政年份:
    2013
  • 资助金额:
    $ 31.9万
  • 项目类别:

相似国自然基金

温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
  • 批准号:
    12302265
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
  • 批准号:
    52308322
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
  • 批准号:
    52373051
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
  • 批准号:
    42377282
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
  • 批准号:
    52376132
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
  • 批准号:
    10644874
  • 财政年份:
    2023
  • 资助金额:
    $ 31.9万
  • 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
  • 批准号:
    10589192
  • 财政年份:
    2023
  • 资助金额:
    $ 31.9万
  • 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
  • 批准号:
    10696538
  • 财政年份:
    2023
  • 资助金额:
    $ 31.9万
  • 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
  • 批准号:
    10678341
  • 财政年份:
    2023
  • 资助金额:
    $ 31.9万
  • 项目类别:
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
  • 批准号:
    10679988
  • 财政年份:
    2023
  • 资助金额:
    $ 31.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了